Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Veracyte, Inc.

Di cosa scriviamo

BiotecnologiaOncologiaSaluteSoftwareTecnica

39 comunicati stampa

Guarda tutti i comunicati
29/12/2026
Tecnica
Attrezzature medico-sanitarie
Biotecnologia
Software
Salute
Oncologia
Eventi
Web e Social Network
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
06/11/2025
Tecnica
Comunicazione
Biotecnologia
Software
Salute
Oncologia
Web e Social Network
Eventi
Finanza
Veracyte to Participate in Upcoming Investor Conferences
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
04/11/2025
Oncologia
Information Technology
Salute
Tecnica
Sanità
Software
Web e Social Network
Telefonia e Varie
Mercato azionario
Veracyte Announces Third Quarter 2025 Financial Results
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
03/11/2025
Sanità
Scienza
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Assistenza all'Infanzia
Salute
Industria
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
15/10/2025
Oncologia
Information Technology
Salute
Tecnica
Sanità
Software
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
28/09/2025
Biotecnologia
Salute
Medicina nucleare
Oncologia
Scienza
Attrezzature medico-sanitarie
Medicina - Varie
Eventi
Fiere
Industria
Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
24/09/2025
Eventi
Industria
Scienza
Medicina nucleare
Farmaceutica
Oncologia
Vetrine/Shopping
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Salute
Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
09/09/2025
Oncologia
Salute
Tecnica
Biotecnologia
Software
Eventi
Industria
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
29/08/2025
Oncologia
Salute
Tecnica
Biotecnologia
Software
Web e Social Network
Eventi
Finanza
Veracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0
27/08/2025
Sanità
Tecnica
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Tecnologie Varie
Scienza
Software
Salute
Industria
Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
Fonte
Veracyte, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0